Journal
PHARMACEUTICALS
Volume 14, Issue 9, Pages -Publisher
MDPI
DOI: 10.3390/ph14090869
Keywords
obesity; metabolism; anti-obesity combined medications; weight loss; incretins
Categories
Funding
- Hellenic Medical Association for Obesity
Ask authors/readers for more resources
The global trend of increasing obesity rates presents challenges in finding effective long-term treatments. Current anti-obesity drugs have limited effectiveness and potential side effects, leading researchers to explore the use of combined medications targeting multiple pathways for better outcomes in obesity management.
The worldwide upward trend in obesity in adults and the increased incidence of overweight children suggests that the future risk of obesity-related illnesses will be increased. The existing anti-obesity drugs act either in the central nervous system (CNS) or in the peripheral tissues, controlling the appetite and metabolism. However, weight regain is a common homeostatic response; current anti-obesity medications show limited effectiveness in achieving long-term weight loss maintenance; in addition to being linked to various side effects. Combined anti-obesity medications (per os or injectable) target more than one of the molecular pathways involved in weight regulation, as well as structures in the CNS. In this systematic review, we conducted a search of PubMed and The ClinicalTrials.gov up to February 2021. We summarized the Food and Drug Administration (FDA)-approved medications, and we focused on the combined pharmacological treatments, related to the incretin hormones, currently in a clinical trial phase. We also assessed the mechanism of action and therapeutic utility of these novel hybrid peptides and potential interactions with other regulatory hormones that may have beneficial effects on obesity. As we improve our understanding of the pathophysiology of obesity, we hope to identify more novel treatment strategies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available